ArticleThe Lancet regional health. Western Pacific2025

Regulatory flexibilities balancing unmet needs, benefits and risks in the approvals of imported cancer drugs in China: a cohort study from 2012 to 2021.

Xiangyun Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.